cholestyramine resin has been researched along with atenolol in 1 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (atenolol) | Trials (atenolol) | Recent Studies (post-2010) (atenolol) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 5,473 | 1,950 | 852 |
| Protein | Taxonomy | cholestyramine resin (IC50) | atenolol (IC50) |
|---|---|---|---|
| Beta-1 adrenergic receptor | Homo sapiens (human) | 0.7468 | |
| Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.23 | |
| Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.23 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Burman, KD; Solomon, BL; Wartofsky, L | 1 |
1 trial(s) available for cholestyramine resin and atenolol
| Article | Year |
|---|---|
Adjunctive cholestyramine therapy for thyrotoxicosis.
Topics: Adult; Atenolol; Chemotherapy, Adjuvant; Cholestyramine Resin; Double-Blind Method; Female; Graves Disease; Humans; Male; Methimazole; Middle Aged; Thyroid Hormones; Thyrotoxicosis | 1993 |